Académique Documents
Professionnel Documents
Culture Documents
A.
Amount
Amount
As at 31.3.08 Valuation
(Audited)
Adjustments
( Book Values)
Rs/lacs
Rs/lacs
Amount
As
Adjusted
FMV
Rs/lacs
44.87
1.08
45.95
28.03
8.67
36.70
72.90
9.75
82.65
B.
13.90
13.90
C.
59.85
36.70
96.55
D.
97.61
97.61
E.
157.46
36.70
194.16
F.
38.93
38.93
G.
Unsecured Borrowings
68.36
68.36
H.
I.
12.47
(6.63)
0.00
5.84
5.84
50.17
30.86
81.02
30.00
58.80
(38.63)
0
0
30.86
30.00
58.80
-7.77
50.17
30.86
81.03
Represented By :
Share Capital
Share premiun
Less Debit Balance in Profit & Loss a/c
J.
Net worth
K.
L.
300,000
300,000
16.72
27.01
UNDERLYING ASSUMPTIONS :
1 Market Value of Factory Land & Building and Office Premises has been taken based on Valuation Reports of a
approved valuer.
2 Deferred Tax Liability on increase in value of immovable properties has been taken @ 33.99% ( being the
income tax rate on companies)
Amount
2007-08
2006-07
(Audited)
Rs/lacs
(Audited)
Rs/lacs
Revenue
190.00
139.33
Less Costs
162.65
122.61
27.35
16.72
4.35
4.40
23.00
12.32
69.00
24.64
18.82
6.40
7.82
4.19
12.42
15.18
8.13
0.07
0.29
0.06
0.80
0.04
Capitalisation Rate
Capitalised Future Maintainable Profits
No. of Equity Shares ( Rs. 10/- per share)
Value per Share ( Rs./ Share)
15%
82.82
300,000
27.61
0.24
0.66
0.84
3.01
4.21
10.21
0.11
17.54
0.01
4.89
5.41
0.08
10.39
Method of Valuation
Value of
Share
Rs./Share
16.72
27.61
Average
22.17
3.32
18.84
Amount
2005-06
(Audited)
Rs/lacs
118.60
94.33
24.27
4.99
19.28
1
19.28
6.55
12.73
0.00
0.24
0.24
0.47
12.88
2.75
0.12
16.22
-0.01
B.
C.
Higher of A & B
A Guidelines
1.98
13.41
8.05
15.93
16.72
2.31
1.39
23.18
23.18
2007-08
2006-07
2005-06
Normalized Normalized Normalized
Rs/lacs
Rs/lacs
Rs/lacs
Revenue
190.00
139.33
118.60
Less Costs
155.65
114.99
85.91
34.35
24.34
32.69
7.00
7.62
8.42
27.35
16.72
24.27
82.05
33.44
24.27
9.50
9.30
5.68
8.25
18.45
18.05
11.04
16.02
EBITDA
Less Depreciation
EBIT
Weights assigned
Products
Weighted Average
23.29
27.95
3.39
2.87
2.90
3.29
15.06
15.18
8.13
12.73
1.00
1.50
11.04
-6.53
8.35
4.37
1.52
8.99
UNDERLYING ASSUMPTIONS:
1 Since there is no discernible trend in the profits during the past years, the weighted average of historical
results for the last 3 years have been taken.
2 The followings are in the nature of abnormal, non-recurring or extra-ordinary items
and therefore, have been excluded from the Total Revenues.
Exclusion from Total Revenue
Miscellaneous Income
Sundry Balance Written Back
Interest on Bank FDs
Gain /(Loss)on Disposal of Fixed Assets
0.07
0.29
0.06
0.24
0.66
0.80
0.04
0.00
0.24
0.84
0.24
4 Growth Rates
Intial Growth rate 6 years
20%
Perpetual Growth rate beyond
5%
Blended Growth rate
11.34%
( Long term average annual componded growth rate)
3.01
4.21
10.21
0.11
17.54
0.01
4.89
5.41
0.08
10.39
0.47
12.88
2.75
0.12
16.22
erage of historical
-6.56
S No.
1
2
3
4
5
6
7
8
9
Company Name
Levered
Beta
Debt
Equity
(Book)
Equity
(Market)
D/E Ratio
1
666.34
639.56
531.33
0.7
255.47
340.82
170.56
0.5
240.66 2951.85
266.4
0.5
336.69
333.08
712.86
0.9 1161.75
671.73
614.25
1.1
67.43
512.76
342.86
0.6 5025.98 6424.81 27913.32
0.4
369.76
415.48
270.3
0.8 15348.20 17883.90 25538.64
6.50
Total
1.25
1.50
0.90
0.47
1.89
0.20
0.18
1.37
0.60
6.60
0.15
Unlevered
Beta
Tax @ 33.99%
0.55
0.35
0.31
0.38
0.40
0.97
0.54
0.21
0.57
4.29
0.48
7.00%
14.00%
1.00
4.00%
4.00%
Cost of Equity
( being return required by an investor)
22.00%
2 Cost of debt
Unsecured Borrowings( in Euro)
Interest rate in Euro
Spot Rate
Forward ( one year)
5.334%
Rs./Euro
Rs./Euro
69.1275
70.5584
7.5144%
2.18%
7.5144%
10%
33.99%
6.60%
31.3.09 31.3.10
22.00%
Rs./Lacs
18.45
1.00
1.50
15.95
22.14
2.00
1.80
18.34
26.57
3.00
2.16
21.41
31.88
4.00
2.59
25.29
38.26
5.00
3.11
30.15
45.91
5.00
3.73
37.18
0.82
13.07
0.67
12.32
0.55
11.79
0.45
11.42
0.37
11.16
0.30
11.28
48.21
10.00
3.92
34.29
201.70
0.30
61.17
5.14
1.75
0.91
4.31
1.46
0.83
3.43
1.17
0.75
2.51
0.85
0.68
1.54
0.53
0.62
0.52
0.18
0.56
0.00
0.00
0.00
1.59
1.21
0.88
0.58
0.33
0.10
0.00
132.21
33.99%
10.00%
4.68
136.89
63.80
73.09
24.36
11.04
3.65
1.49
16.17
11.62
3.06
1.25
15.93
12.24
2.44
1.00
15.68
12.90
1.78
0.73
15.41
13.59
1.10
0.45
15.13
6.97
0.37
0.15
7.49
0.93
15.04
0.87
13.78
0.80
12.62
0.75
11.53
0.70
10.53
0.65
4.85
0.83
13.17
0.75
11.78
0.68
10.53
0.62
9.40
0.56
4.23
7.51%
68.36
21240
5.334%
1
2
3
4
5
6
5%
20%
22.00%
11.34%
.20-g
2.064
1.064
11.34%
68.36
57.33
45.70
33.46
20.56
6.97
3.65
3.06
2.44
1.78
1.10
0.37
14.68
14.68
14.68
14.68
14.68
7.34
principal
repaid
57.33
11.04
45.70
11.62
33.46
12.24
20.56
12.90
6.97
13.59
0.00
6.97
12.40
80.75
68.36
(I)
Current liab. & Provs.
Current Laibilities
provisions
(ii)
Sales
Other Income
Total Income
Mar-08
(12 Months)
Mar-08
(12 Months)
Mar-08
(12 Months)
Fixd Assets
Gross Block
(-) Acc. Depreciation
Net Block (A)
Capital work in prgs.(B)
Investments (C)
Current Asstes, Loan & Advs.
inventories
Sundry Debtors
Cash & Bank
Loans & advances
Alkhli Metals
127.88
511.68
639.56
637.23
29.11
1,305.90
Assets
69.39
271.43
340.82
237.37
18.10
596.29
Mar-08
(12 Months)
Chembond Chem.
Mar-08
(12 Months)
30.00
171.04
201.04
51.21
28.48
280.73
Mar-08
(12 Months)
773.40
222.82
550.58
330.86
16.76
418.46
101.49
316.97
0.00
0.00
137.13
29.85
107.28
17.17
35.72
225.45
357.19
44.38
336.98
964.00
130.93
121.00
0.41
95.56
347.90
117.27
169.33
4.68
63.55
354.83
374.55
181.75
556.30
407.70
0.00
1305.90
-
77.64
0.00
77.64
270.26
9.06
596.29
-
170.97
63.31
234.28
120.54
0.00
280.71
0.02
1958.84
16.99
1975.83
Alkhli Metals
Mar-08
(12 Months)
617.68
0.42
618.10
Chembond Chem.
Mar-08
(12 Months)
955.20
26.70
981.90
1040.36
225.54
423.85
1689.75
326.41
69.36
96.62
492.39
798.10
173.76
-67.14
904.72
Operating Profit
286.08
125.71
77.18
Interest Name
Gross profit
68.79
217.29
17.72
107.99
7.48
69.7
Depreciation
Profit Bef. Tax
37.30
179.99
18.17
89.82
5.65
64.05
Tax
Net Profit
46.25
133.74
10.50
79.32
13.62
50.43
-6.80
126.94
31.97
0.00
79.32
27.75
0.00
50.43
10.50
(I)
dep+int+tax
int+tax
Company Name ----Ratios
152.34
115.04
Grauer & weil
Mar-08
(12 Months)
Alkhli Metals
Mar-08
(12 Months)
Chembond Chem.
Mar-08
(12 Months)
Profitability Ratios %
Operating Profit Margin
Gross Profit Margin
Net Profit Margin
13.73
11.83
6.42
20.28
17.34
12.83
5.28
4.69
5.13
10.30
5.48
2.53
5.25
5.10
1.48
9.63
5.64
6.97
1.73
1.04
3.91
4.48
0.75
7.07
1.51
0.40
6.75
20.60
19.84
29.76
21.01
23.90
40.93
17.98
25.08
24.35
Turnover Ratios %
Inventory Turnover Ratio
Debtor Turnover Ratio
Fixed Asset Turnover Ratio
Solvency Ratios %
Current Ratio
Debt Equity Ratio
Interest Covering Ratio
Performance Ratios %
Return on Investment
Return on Networth
Dividend Yield
Economic times
Market Price
P/E Ratio
EPS
Mkt Cap
41.55
3.7
11.23
531.33
.
Market Price
P/E Ratio
EPS
Mkt Cap
167.75
0
0
170.56
143
6.86
20.85
Ciba India
Dailchi
Dr. Biotech
Gulshan
Mar-08
(12 Months)
Mar-08
(12 Months)
Mar-08
(12 Months)
Mar-08
(12 Months)
132.81
2819.04
2951.85
0.00
240.66
3192.51
Mar-08
(12 Months)
76.06
451.79
527.85
35.96
18.77
582.58
Mar-08
(12 Months)
24.20
6.90
31.10
0.00
2.60
33.70
Mar-08
(12 Months)
145.74
187.34
333.08
334.58
2.11
669.77
Mar-08
(12 Months)
Mar-08
(12 Months)
49.08
83.11
132.19
5.59
0.00
137.78
Mar-08
(12 Months)
1188.81
928.09
260.72
131.70
1508.56
464.78
315.00
149.78
0.43
35.99
0.50
0.30
0.20
0.00
0.10
743.43
288.88
454.55
64.93
2.28
335.21
126.89
208.32
3.56
0.00
147.89
76.35
71.54
1.99
0.00
817.01
758.22
13.17
795.60
2384.00
61.94
116.85
20.70
328.02
527.51
0.00
6.20
0.20
29.50
35.90
92.38
146.27
8.11
43.37
290.13
65.33
32.35
2.05
23.07
122.80
31.98
70.56
2.71
15.11
120.36
1010.38
82.07
1092.45
1291.55
0.00
3192.53
(0.02)
114.94
16.18
131.12
396.39
0.00
582.59
(0.01)
1.90
0.60
2.50
33.4
0.00
33.70
-
133.55
18.72
152.27
137.86
10.15
669.77
-
44.23
11.09
55.32
67.48
0.00
279.36
0.01
51.61
4.49
56.10
64.25
0.00
137.78
-
Ciba India
Mar-08
(12 Months)
4697.95
83.36
4781.31
Dai lchi
Mar-08
(12 Months)
451.73
44.73
496.46
Dr. Biotech
Mar-08
(12 Months)
10.90
0.00
10.90
Gulshan
Mar-08
(12 Months)
994.19
0.04
994.23
311.71
1.72
313.43
210.59
4.95
215.54
3748.13
111.62
510.94
4370.69
311.63
66.44
78.88
456.95
9.40
0.00
0.40
9.80
561.61
120.49
131.28
813.38
183.46
40.73
56.01
280.20
142.30
21.54
29.82
193.66
410.62
39.51
1.10
180.85
33.23
21.88
14.30
396.32
5.82
33.69
0.00
1.10
51.70
129.15
14.49
18.74
1.55
20.33
68.36
327.96
8.52
25.17
0.30
0.80
34.46
94.69
16.16
2.58
6.53
13.80
123.19
204.77
9.28
15.89
0.30
0.50
19.64
75.05
-1.34
3.92
2.22
11.58
-11.39
193.38
46.48
0.00
15.89
9.13
0.00
0.50
0.00
20.71
95.76
4.66
4.31
8.23
0.00
-3.32
8.26
2.45
Ciba India
Mar-08
(12 Months)
Dai lchi
Mar-08
(12 Months)
Dr. Biotech
Mar-08
(12 Months)
Gulshan
Mar-08
(12 Months)
6.69
5.51
4.04
-1.15
-3.04
3.20
10.09
7.33
4.58
18.18
14.72
9.70
10.10
4.92
2.62
8.04
4.94
3.83
5.99
6.20
3.95
8.37
3.87
0.97
0.00
1.76
21.80
12.82
6.80
1.34
5.39
9.63
0.93
7.26
2.98
1.42
2.18
0.08
22.88
4.02
0.10
-0.90
14.36
0.08
0.00
1.91
1.01
3.50
2.22
0.80
2.17
2.15
0.04
10.90
10.25
6.55
28.12
-0.89
3.01
67.19
3.26
1.60
0.00
26.99
46.33
5.64
11.27
5.29
0.00
12.29
6.24
34.77
200.6
7.84
25.6
266.4
24
17.91
1.34
18.26
0
0
0
114.75
6.62
17.33
712.86
14.05
13.64
1.03
9.79
4.26
2.34
Jayant Aqro
Laffancs
Panama
Passari
Mar-08
Mar-08
Mar-08
Mar-08
(12 Months) (12 Months) (12 Months) (12 Months)
124.52
547.21
671.73
770.71
391.04
1833.48
80.00
283.94
363.94
228.02
61.68
653.64
54.00
458.76
512.76
66.84
0.59
580.19
31.82
-12.11
19.71
12.93
0.00
32.64
Mar-08
Mar-08
Mar-08
Mar-08
(12 Months) (12 Months) (12 Months) (12 Months)
Pidilite
Refnol Resins
SNZS
Mar-08
(12 Months)
Mar-08
(12 Months)
Mar-08
(12 Months)
281.82
6142.99
6424.81
1904.27
3121.71
11,450.79
Mar-08
(12 Months)
30.90
-26.75
4.15
27.23
0.00
31.38
Mar-08
(12 Months)
50.00
-68.90
-18.90
0.00
5.20
-13.70
Mar-08
(12 Months)
427.13
126.43
300.70
2.77
123.90
350.39
109.96
240.43
0.00
1.19
91.12
30.96
60.16
0.00
0.24
26.30
7.94
18.36
0.00
6.41
6773.21
2973.48
3799.73
1670.94
1623.69
47.72
36.53
11.19
0.00
8.91
0.00
0.00
0.00
0.00
0.00
1010.12
287.52
33.18
464.09
1794.91
208.77
367.26
5.11
70.11
651.25
968.98
468.76
94.03
122.35
1654.12
0.38
5.02
-0.01
3.11
8.50
2655.44
2057.48
1485.50
924.84
7123.26
19.23
70.01
8.77
14.84
112.85
0.00
0.00
0.00
1.00
1.00
297.90
90.91
388.81
1406.11
0.00
1833.48
-
237.87
1.35
239.22
412.02
0.00
653.64
-
1064.01
70.32
1134.33
519.79
0.00
580.19
-
0.63
0.01
0.64
7.87
0.00
32.64
-
2169.02
597.81
2766.83
4356.43
0.00
11450.79
-
98.55
3.03
101.58
11.28
0.00
31.38
-
14.40
0.30
14.70
-13.70
0.00
-13.70
-
Jayant Aqro
Laffancs
Panama
Passari
Mar-08
Mar-08
Mar-08
Mar-08
(12 Months) (12 Months) (12 Months) (12 Months)
5994.43
67.73
6062.16
1761.13
8.52
1769.65
2339.12
8.45
2347.57
0.00
0.00
0
Pidilite
Mar-08
(12 Months)
15371.88
168.64
15540.52
Refnol Resins
SNZS
Mar-08
Mar-08
(12 Months) (12 Months)
234.82
1.79
236.61
0.00
0.40
0.4
5297.08
0.00
551.68
5848.76
1478.25
260.32
-63.15
1675.42
1972.49
304.66
-142.31
2134.84
0.00
0.00
0.39
0.39
9145.69
1687.78
1912.63
12746.10
158.42
45.85
4.89
209.16
0.00
0.00
2.50
2.5
213.40
94.23
212.73
-0.39
2794.42
27.45
-2.1
105.07
108.33
34.85
59.38
45.55
167.18
0.00
-0.39
205.81
2588.61
6.70
20.75
0.00
-2.1
21.51
86.82
14.37
45.01
3.70
163.48
0.00
-0.39
385.05
2203.56
1.81
18.94
0.00
-2.10
35.48
51.34
16.00
29.01
20.42
143.06
0.45
-0.84
363.22
1840.34
0.45
18.49
0.00
-2.1
10.04
61.38
18.75
-0.14
28.87
0.00
4.92
147.98
22.29
0.00
-0.84
0.00
43.19
1883.53
442.87
12.04
30.53
0.00
0.00
-2.10
0.00
Jayant Aqro
Laffancs
Panama
Passari
Mar-08
Mar-08
Mar-08
Mar-08
(12 Months) (12 Months) (12 Months) (12 Months)
Pidilite
Mar-08
(12 Months)
Refnol Resins
SNZS
Mar-08
Mar-08
(12 Months) (12 Months)
2.43
2.07
1.01
4.86
4.05
1.63
8.73
8.57
6.30
0.00
0.00
0.00
17.08
14.57
12.09
10.93
10.16
12.91
0.00
0.00
-525.00
5.98
20.85
14.03
9.68
4.80
5.03
2.73
4.99
25.67
0.00
0.00
0.00
7.07
7.47
2.60
14.59
3.35
4.92
0.00
0.00
0.00
4.62
1.73
1.39
2.72
0.80
2.46
1.46
0.13
4.48
13.41
0.66
0.00
2.57
0.78
12.76
1.11
6.56
3.83
0.07
-0.28
0.00
7.94
9.61
37.60
13.11
7.97
0.00
35.20
29.22
15.06
-1.18
-4.24
0.00
22.93
29.38
27.56
81.80
735.61
0.00
18.24
0.00
0.00
40.7
7.86
5.21
614.25
11.6
1.65
7.02
72
1.55
46.55
342.86
16
110
14.27
7.73
27913.32
7.08
1.26
5.63
3.75
46.88
0.08
Sunshield
Transpek
United Phosphorus
Mar-08
(12 Months)
Mar-08
(12 Months)
Mar-08
(12 Months)
73.53
40.98
114.51
137.29
123.85
375.65
Mar-08
(12 Months)
56.73
358.75
415.48
230.29
139.47
785.24
Mar-08
(12 Months)
1292.10
16591.80
17883.90
2045.50
13302.70
33232.10
Mar-08
(12 Months)
350.36
92.71
257.65
0.99
0.03
949.19
364.64
584.55
20.09
47.35
11805.50
4895.30
6910.20
1273.00
8312.0
52.97
89.35
3.47
26.94
172.73
158.65
203.29
27.92
140.06
529.92
3022.70
4985.20
3038.30
14556.60
25602.80
55.75
0.00
55.75
116.99
0.00
375.66
(0.01)
356.21
40.47
396.68
133.25
0.00
785.24
-
8351.90
514.00
8865.90
16736.90
0.00
33232.10
-
Sunshield
Mar-08
(12 Months)
418.51
7.20
425.71
Transpek
United Phosphorus
Mar-08
Mar-08
(12 Months)
(12 Months)
1067.36
32.83
1100.19
15411.20
1394.60
16805.8
305.46
55.38
25.32
386.16
604.85
74.44
306.99
986.28
9368.70
1119.30
3743.70
14231.70
39.55
113.91
2574.1
27.76
11.79
44.05
69.86
1123.60
1450.5
13.94
-2.15
49.94
19.92
669.10
781.40
0.68
-2.83
9.26
10.66
18.90
762.5
-2.52
-5.35
0.00
1.31
11.97
0.00
156.60
919.10
439.30
Sunshield
Mar-08
(12 Months)
Transpek
United Phosphorus
Mar-08
Mar-08
(12 Months)
(12 Months)
7.72
4.39
-0.66
7.59
2.91
1.02
7.65
3.31
5.50
8.95
4.68
1.19
7.20
5.25
1.15
6.03
3.09
1.48
3.10
2.28
1.16
1.34
0.89
1.84
2.89
0.86
1.05
8.60
-2.48
0.00
10.32
2.72
83.14
3.54
5.43
55.55
Mean
13.76
11.76
1.17
50.7
4.81
10.51
270.3
116
13.77
8.44
25538.64
Median
Standard Deviation
Coff. Of Variation
1821
Company Name
Gross
Cash
Mkt Cap Book Equity
Pretax Earning
Net Income Flow
639.56
340.82
2951.85
333.08
671.73
512.76
6424.81
415.48
17883.90
639.56
179.99
89.82
327.96
94.69
86.82
163.48
2203.56
19.92
781.40
Company Name
MV Eq/
Pretax
Earnings
MV Eq./
Net
Income
EBITDA
Sales
MV
Eq/Gross
MV
MVIC/EBI MVIC/E
Cash Flow Eq/Sales
TDA
BIT
0.83
0.50
0.09
2.14
0.91
0.67
4.34
0.65
1.43
2.95
1.90
0.81
7.53
7.07
2.10
12.67
13.57
32.68
3.97
2.15
1.30
9.50
11.96
2.40
15.17
25.36
33.49
3.11
1.75
0.98
6.51
8.43
2.34
12.54
4.46
17.84
0.27
0.28
0.06
0.72
0.10
0.15
1.82
0.25
1.66
4.19
3.39
1.23
5.80
8.32
1.93
11.79
5.62
15.88
4.81
3.96
1.48
7.17
9.26
1.96
13.67
10.01
21.46
Mean
Median
Standard Deviation
Coff of Variation
1.29
0.83
1.29
100.25
9.03
7.07
10.02
110.92
11.70
9.50
11.31
96.70
6.44
4.46
5.64
87.66
0.59
0.27
0.68
115.40
6.46
5.62
4.80
74.27
8.20
7.17
6.37
77.71
Notes
As per S Pratt multiple with lower coff of variation is to be given more weights Pg 299
For coff of variation we need to calculate mean
Median is considered as better measure than Mean for skewed data, so median is considered for calculaion of target
the median is not influenced by outliers at the extremes of the data set. For this reason, the median often is used whe
In the investing world, the coefficient of variation allows you to determine how much volatility (risk) you are assuming i
122
474
Max
17.84
Min
0.98
Tangible
EBIT Asset Value
dep
248.78
107.54
342.26
146.39
191.89
209.03
###
63.97
###
1197.67
426.03
507.06
1049.55
1776
410.29
32939.3
640.06
40886.84
37.30
18.17
68.36
34.46
21.51
3.70
385.05
49.94
669.10
37.30
639.56
331.76
2951.85
322.93
671.73
512.76
6424.81
415.48
17883.90
6.83%
12.84%
4.36%
7.55%
0.86%
6.12%
11.97%
1.00%
4.95%
6.12%
44.36%
40.03%
52.54%
67.92%
34.59%
83.57%
84.74%
42.23%
62.46%
52.54%
dep+int+tax int+tax
152.34
46.39
205.85
105.80
162.06
69.67
954.08
103.25
1811.60
152.34
115.04
28.22
137.49
71.34
140.55
65.97
569.03
53.31
1142.50
115.04
tax
46.25
10.50
123.19
19.64
35.48
20.42
363.22
9.26
18.90
20.42
MVIC/Tangib
le Asset
Value
0.61
0.69
0.11
1.06
0.30
0.18
2.14
0.60
2.65
1.87
1.28
0.17
3.25
2.64
0.80
5.13
1.54
2.29
0.93
0.61
0.89
96.39
2.11
1.87
1.47
69.65
atility (risk) you are assuming in comparison to the amount of return you can expect from your investment. In simple language, the lower the
5.13
0.17
Guideline Public Company Method - Value Summary - Relative to Grauer & Weil
Equity Multiples
Multiple Adjusted
KECPL
Indicated
of Grauer Multiple X Funda= Value & weil
-mental
3.97
3.01
15.18
45.77
3.11
2.49
22.18
55.19
2.95
3.86
23.00
88.67
0.27
0.21
190.00
0.00
0.83
0.63
50.17
31.63
4.19
4.81
0.61
1.87
3.64
4.11
0.46
1.42
34.35
27.35
190.00
50.17
125.20
112.45
88.15
71.29
Debt
=
0
0
0
0
0
68.36
68.36
68.36
68.36
The equity capitalization rate for the subject company has been kept larger by 8% ( 4% for size d
4% for Company specific risks) than the comparable rates for guidelines company. Accordin
multiples have been adjusted.
Indicated
Weight
Weighted
Equity X
=
Value
Value
45.77
0.05
2.29
55.19
0.10
5.52
88.67
0.05
4.43
0.00
0.05
0.00
31.63
0.05
1.58
56.84
44.09
19.79
2.93
0.20
0.20
0.10
0.20
1
11.37
8.82
1.98
0.59
36.57
Selected
KECPL
Indicated
Multiple X Funda= Value -mental
9.50
15.18
144.21
4.46
22.18
98.94
7.07
23.00
162.72
0.27
190.00
51.54
0.83
50.17
41.68
5.62
7.17
0.61
1.87
34.35
27.35
190.00
50.17
193.01
196.09
116.17
93.95
Debt
Indicated
= Equity X
Value
0
144.21
0
98.94
0
162.72
0
51.54
0
41.68
68.36
68.36
68.36
68.36
124.65
127.72
47.81
25.59
Weight
Weighted
= Value
0.05
0.10
0.05
0.05
0.05
7.21
9.89
8.14
2.58
2.08
0.20
0.20
0.10
0.20
1
24.93
25.54
4.78
5.12
90.27
Value
Less
Less
Total
100 % Non
derived DLOC DLOM
Marketable
methods
Discount Minority V.
(Rs./Lacs)
(Rs./Lacs)
81.03
15%
25%
36%
51.65
73.09
5%
25%
29%
52.08
90.27
36.57
5%
5%
25%
25%
29%
29%
64.32
26.06
4 CCI
66.50
0%
15%
15%
56.52
115.89
0%
40%
40%
69.54
5 FEMA Guidelines
Value
Per share
Rs.
17.22
17.36
21.44
8.69
18.84
23.18
sales cagr
38054800
0.164
cagr
aagr
1.153882
0.153882
0.038471
0.036431
0.036747
ces in the
Contracts as at
-----------------------------AUG.2009 NOV.2009
-----------------------------50.9200
51.0450
78.4750
78.7075
65.4850
65.7050
54.1075
54.4450
0.9700
1.6500
1.3325
1.94%
2.14%
2.07%
69.1275
1.430928
70.55843
1000 69127.5
53.34
1053.34 74322.01
5194.514
1.430928
0.0207
7.51%
For F.E.D.A.I.
Dy.Chief Executive
7.51%
32979800
5075000
0.1538820733
18.03
4.5075
38054800
35497100
35201800
34627900
32979800
0.072054
0.008389
0.016573
0.049973
0.146989
0.036747